Second Biennial Symposium on Biology, Diagnosis and Treatment of Lymphomas

The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 21 de abril del 2002

Share article


Conference Dates: Friday, October 4, 2002
Conference Location: Philadelphia Marriott West, 111 Crawford Ave., West Conshohocken, PA


Sponsoring Group: University of Pennsylvania Cancer Center

Conference Brochure:
Brochure View the full conference brochure as a PDF. You will need Adobe Acrobat Reader which is available free online.

Topics Covered:

  • WHO Classification of Lymphomas
  • Biology of Lymphomas
  • Pathogenesis of Hodgkin's lymphoma
  • High Resolution Cytogenetics
  • Pet Scanning
  • Lymphoma Vaccines

Conference Objectives: At the completion of the program, participants should be able to:

  1. Discuss the current classification of lymphomas, as well as the controversies in diagnosis and their impact on management
  2. Explain the growing role of understanding the basic mechanisms of the disease in diagnosis and treatment of lymphomas
  3. Discuss the various diagnostic tests in evaluation of patients with lymphomas
  4. Describe to patients the current therapeutic options and identify controversies in the treatment of various types of lymphoma
  5. Critically assess novel diagnostic and therapeutic approaches to lymphomas

Who Should Attend: Pathologists, Hematopathologists, Oncology Nurses, Oncology Social Workers, Radiation Oncologists

Conference Agenda:

  • 8:00-8:15 Welcome and Introduction - Stephen G. Emerson, MD 8:15-8:45 WHO Classification of Lymphomas - Jay Hess, MD
  • 8:45-9:15 Biology of Lymphomas: Diagnostic and Therapeutic Implications - Mariusz A. Wasik, MD 9:15-9:45 Pathogenesis of Hodgkin's Lymphoma - Adam Bagg, MD
  • 9:45-10:00 Questions and Answers
  • 10:00-10:15 Break
  • 10:15-11:00 Nodal, Extranodal (MALT) and Splenic Marginal Zone Lymphomas: A Spectrum of Diverse Entities - Hans K. Muller-Hermelink, MD
  • 11:00-11:45 High Resolution Cytogenetics: Insights into Pathogenesis of Large B-Cell Lymphomas - Raju SK Chaganti, PhD
  • 11:45-12:00 Discussion
  • 12:00-1:00 Lunch
  • 1:00-1:30 PET Scanning as a Diagnostic Tool in Lymphomas - Abass Alavi, MD
  • 1:30-2:00 Management of Lymphomas in Geriatric Patients - Sunita Nasta, MD
  • 2:00-2:30 Antibody-Based Therapy of Lymphomas - Stephen Schuster, MD
  • 2:30-3:00 Immunomodulators in Treatment of Lymphomas - Alain Rook, MD
  • 3:00-3:15 Questions and Answers
  • 3:15-3:30 Break
  • 3:30-4:00 Lymphoma Vaccines - Larry Kwok, MD
  • 4:00-5:00 Case Presentations: CNS Lymphoma in HIV+ Patient Blastic NK-Cell Lymphoma

Registration Information: To register contact Mary Graham at (215) 662-7328 or grahamm@mail.med.upenn.edu

Conference Fees: $160.00 Physicians; $95.00 Nurses and Other Health Care Professionals; No fee for faculty, staff or students of the University of Pennsylvania

Continuing Education: Continuing Medical Education credits will be offered.


News
Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información